XCEM vs. REVS
XCEM (Columbia EM Core ex-China ETF) and REVS (Columbia Research Enhanced Value ETF) are both exchange-traded funds - XCEM is a Emerging Markets Equities fund tracking the MSCI Emerging Markets ex China Index, while REVS is a Large Cap Value Equities fund tracking the Beta Advantage Research Enhanced U.S. Value Index. Both are passively managed. Over the past 5 years, XCEM returned 10.85%/yr vs 12.19%/yr for REVS. A 0.56 correlation means they provide meaningful diversification when combined. XCEM charges 0.16%/yr vs 0.19%/yr for REVS.
Performance
XCEM vs. REVS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XCEM achieves a 29.80% return, which is significantly higher than REVS's 14.87% return.
XCEM
- 1D
- 1.49%
- 1M
- -3.73%
- 6M
- 24.35%
- YTD
- 29.80%
- 1Y
- 50.50%
- 3Y*
- 22.27%
- 5Y*
- 10.85%
- 10Y*
- 11.28%
REVS
- 1D
- -0.47%
- 1M
- 1.65%
- 6M
- 11.65%
- YTD
- 14.87%
- 1Y
- 24.70%
- 3Y*
- 18.00%
- 5Y*
- 12.19%
- 10Y*
- —
XCEM vs. REVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
XCEM Columbia EM Core ex-China ETF | 29.80% | 34.05% | 0.42% | 19.96% | -17.59% | 7.87% | 9.47% | 10.66% |
REVS Columbia Research Enhanced Value ETF | 14.87% | 16.80% | 16.36% | 13.46% | -6.20% | 28.52% | 1.37% | 7.27% |
Correlation
The correlation between XCEM and REVS is 0.47, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.47 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.50 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.58 |
Correlation (All Time) Calculated using the full available price history since Sep 25, 2019 | 0.56 |
The correlation between XCEM and REVS shifts across timeframes, from 0.47 (1 year) to 0.58 (5 years), reflecting how their relationship changes across market environments.
XCEM vs. REVS - Sectors Allocation Comparison
Sectors
XCEM
REVS
Technology
Financial Services
Industrials
Basic Materials
Consumer Cyclical
Energy
Communication Services
Consumer Defensive
Healthcare
Utilities
Real Estate
Technology
XCEM
REVS
Financial Services
XCEM
REVS
Industrials
XCEM
REVS
Basic Materials
XCEM
REVS
Consumer Cyclical
XCEM
REVS
Energy
XCEM
REVS
Communication Services
XCEM
REVS
Consumer Defensive
XCEM
REVS
Healthcare
XCEM
REVS
Utilities
XCEM
REVS
Real Estate
XCEM
REVS
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XCEM vs. REVS — Risk / Return Rank
XCEM
REVS
XCEM vs. REVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Columbia EM Core ex-China ETF (XCEM) and Columbia Research Enhanced Value ETF (REVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XCEM | REVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.13 | ||
| Sortino ratioReturn per unit of downside risk | -0.57 | ||
| Omega ratioGain probability vs. loss probability | 1.38 | 1.37 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 3.51 | 3.58 | -0.07 |
| Martin ratioReturn relative to average drawdown | 12.28 | 13.00 | -0.72 |
Loading charts...
Drawdowns
XCEM vs. REVS - Drawdown Comparison
The maximum XCEM drawdown since its inception was -41.24%, which is greater than REVS's maximum drawdown of -37.85%. Use the drawdown chart below to compare losses from any high point for XCEM and REVS.
Loading charts...
Drawdown Indicators
| XCEM | REVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -41.24% | -37.85% | -3.39% |
Max Drawdown (1Y)Largest decline over 1 year | -14.46% | -6.94% | -7.52% |
Max Drawdown (3Y)Largest decline over 3 years | -18.92% | -16.37% | -2.55% |
Max Drawdown (5Y)Largest decline over 5 years | -29.57% | -18.04% | -11.53% |
Max Drawdown (10Y)Largest decline over 10 years | -41.24% | — | — |
Current DrawdownCurrent decline from peak | -9.41% | -0.47% | -8.94% |
Average DrawdownAverage peak-to-trough decline | -8.56% | -4.60% | -3.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.12% | 1.91% | +2.21% |
Volatility
XCEM vs. REVS - Volatility Comparison
Columbia EM Core ex-China ETF (XCEM) has a higher volatility of 11.62% compared to Columbia Research Enhanced Value ETF (REVS) at 3.02%. This indicates that XCEM's price experiences larger fluctuations and is considered to be riskier than REVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XCEM | REVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.62% | 3.02% | +8.60% |
Volatility (6M)Calculated over the trailing 6-month period | 23.61% | 8.44% | +15.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.20% | 11.55% | +13.65% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.85% | 14.88% | +3.97% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.96% | 19.02% | +0.94% |
XCEM vs. REVS - Expense Ratio Comparison
XCEM has a 0.16% expense ratio, which is lower than REVS's 0.19% expense ratio. Despite the difference, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.
Dividends
XCEM vs. REVS - Dividend Comparison
XCEM's dividend yield for the trailing twelve months is around 2.51%, more than REVS's 1.85% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVS Columbia Research Enhanced Value ETF | 1.85% | 2.13% | 1.89% | 2.49% | 2.46% | 1.18% | 27.75% | 0.70% | 0.00% | 0.00% | 0.00% | 0.00% |
XCEM Columbia EM Core ex-China ETF | 2.51% | 3.25% | 2.76% | 1.22% | 2.42% | 1.94% | 1.63% | 2.11% | 2.70% | 9.56% | 1.24% | 2.63% |
Frequently Asked Questions
XCEM and REVS have a correlation of 0.47, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XCEM has higher volatility (11.62%) compared to REVS (3.02%). In terms of maximum drawdown, XCEM dropped -41.24% vs REVS's -37.85%.
On 5-year performance, REVS leads with 12.19% vs 10.85% for XCEM. On fees, XCEM is cheaper at 0.16% per year. On volatility, REVS has been the lower-risk option at 3.02%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, REVS has performed better with a 12.19% return vs 10.85%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XCEM is cheaper with a 0.16% expense ratio, compared with 0.19% for REVS.
XCEM has the higher dividend yield at 2.51%, compared with 1.85% for REVS.
XCEM is categorized as Emerging Markets Equities, while REVS is Large Cap Value Equities. XCEM tracks MSCI Emerging Markets ex China Index, while REVS tracks Beta Advantage Research Enhanced U.S. Value Index. Their fees differ too: 0.16% for XCEM and 0.19% for REVS.
REVS currently has the higher Sharpe Ratio (2.15 vs 2.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XCEM and REVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer